News

Patents have now been issued in Europe, USA, Japan, Australia and Singapore.

EPI collaborates on Liquid Tissue® personalized medicine assays in lung cancer treatment.

Appointment of three non-executive directors and two business development managers to Cobra Biologics’ board.

Eight million samples from three-generation study will be managed by automated system.

Researchers at the University of Georgia have taken a major step in the ongoing effort to find sources of cleaner, renewable energy by mapping the genomes of two originator cells of Miscanthus x giganteus, a large perennial grass with promise as a source of ethanol and bioenergy.

Service offering expected to advance research programs involved with toxicity assessment, high content screening, and cell-cell communication.

Professor Morris is co-Director of the Medical Research Institute at the University of Dundee and an internationally renowned expert in diabetes and health informatics.

Instrument detected beating rhythm and proarrhythmic effects of nine different compounds on a monolayer of cells, providing evidence for the potential of future screening assays.

Select Biosciences, organisers of the Second European Lab Automation (ELA) at the Congress Center Hamburg, Germany from 30th-31st May 2012, is pleased to offer a ‘bring a buddy’ discount on conference registration fees.

The company presented preclinical studies of AT3375 as a monotherapy and in combination with enzyme replacement therapy for Gaucher disease during the 8th Annual Lysosomal Disease Network WORLD Symposium.